# Long-Term Safety, Tolerability and Efficacy in Perampanel Treated Parkinson's Disease Patients With Motor Fluctuations

> **NCT01634360** · PHASE2 · TERMINATED · sponsor: **Eisai Inc.** · enrollment: 185 (actual)

## Conditions studied

- Parkinson's Disease

## Interventions

- **DRUG:** Perampanel

## Key facts

- **NCT ID:** NCT01634360
- **Lead sponsor:** Eisai Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2004-11
- **Primary completion:** 2008-06
- **Final completion:** 2008-06
- **Target enrollment:** 185 (ACTUAL)
- **Why stopped:** Due to termination of clinical program for Parkinson's Disease
- **Last updated:** 2014-07-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01634360

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01634360, "Long-Term Safety, Tolerability and Efficacy in Perampanel Treated Parkinson's Disease Patients With Motor Fluctuations". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01634360. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*